Faculty Profile


Mariam Nawas
Section of Hematology / Oncology
Assistant Professor of Medicine
Referring Physician Access Line: 1-877-DOM-2730

Academic Interests

Dr. Nawas' academic interests are focused on improving patient-reported outcomes and survival of older adults undergoing cellular therapy
 

Clinical Interests

Treatment of leukemias and MDS, and allogeneic hematopoietic cell transplantation
 

Publications

  • Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves. Nawas MT, Shah GL, Feldman DR, Ruiz JD, Robilotti EV, Aslam AA, Dundas M, Kamboj M, Barker JN, Cho C, Chung DJ, Dahi PB, Giralt SA, Gyurkocza B, Lahoud OB, Landau HJ, Lin RJ, Mailankody S, Palomba ML, Papadopoulos EB, Politikos I, Ponce DM, Sauter CS, Shaffer BC, Scordo M, van den Brink MRM, Perales MA, Tamari R.Transplant Cell Ther. 2021 May;27(5):438.e1-438.e6.
  • Serial comprehensive geriatric and quality of life assessments in adults age = 50 years undergoing autologous hematopoietic cell transplantation.Nawas MT, Sheng Y, Huang CY, Andreadis C, Martin TG, Wolf JL, Ai WZ, Kaplan LD, Mannis GN, Logan AC, Damon LE, Olin RL.J Geriatr Oncol. 2021 May;12(4):531-539
  • The clinical implications of clonal hematopoiesis in hematopoietic cell transplantation.Nawas MT, Schetelig J, Damm F, Levine RL, Perales MA, Giralt SA, VanDenBrink MR, Arcila ME, Zehir A, Papaemmanuil E, Klussmeier A, Schmidt AH, Maiwald S, Bolton KL, Tamari R.Blood Rev. 2021 Mar;46:100744
  • Pilot Study of Telehealth Evaluations in Patients Undergoing Hematopoietic Cell Transplantation. Nawas MT, Landau HJ, Sauter CS, Featherstone CA, Kenny SA, Rodriguez ES, Johnson LG, Giralt SA, Scordo M.Biol Blood Marrow Transplant. 2020 Jun;26(6):e135-e13
  • Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell Transplantation. Nawas MT, Andreadis C, Martin TG, Wolf JL, Ai WZ, Kaplan LD, Mannis GN, Logan AC, Damon LE, Huang CY, Olin RL.Biol Blood Marrow Transplant. 2019 Jun;25(6):1218-122

Training

  • MD, 2013, University of Missouri (UMKC),
  • BA, 2013, University of Missouri (UMKC), Accelerated Baccaluareate/MD
  • Residency, 2017, University of California, San Francisco, Internal Medicine
  • Fellowship, 2021, Memorial Sloan Kettering Cancer Center (MSKCC), Medical Oncology and Hematology